Recombinant Anti-CEA x Anti-GZ (β-galactosidase) Bispecific Antibody (IgG-Fv) (BSGV-139)

Recombinant Anti-CEA x Anti-GZ (β-galactosidase) Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-CEA antibody variable domain is fused to the C terminal of an IgG of anti-GZ (β-galactosidase) antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb can be used in immunoassay.

Datasheet INQUIRY

Specifications

Targets

CEA & GZ (β-galactosidase)

Type

IgG-Fv

Species Reactivity

Human

Application

Immunoassay

Related Disease

Breast cancer; Ovary cancer; Colon cancer; Lung cancer

Targets

Target 1

CEA

Gene ID

1048

UniProt ID

A0A024R0K5

Alternative Names

CEACAM5; carcinoembryonic antigen; carcinoembryonic antigen related cell adhesion molecule 5; CEA; CD66e; meconium antigen 100

Target 2

GZ (β-galactosidase)

Alternative Names

GZ; β-galactosidase; beta-gal; β-gal

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Related products of "CEA & GZ (β-galactosidase)"

See other bsAb targets related to "CEA"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CEA x Anti-GZ (β-galactosidase) Bispecific Antibody (IgG-Fv) (BSGV-139). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CEA x Anti-GZ (β-galactosidase) Bispecific Antibody (IgG-Fv) (CAT#: BSGV-139)

Specifications

Targets

Customer Reviews and Q&As